FDA simplifies approval process for digital mammography devices with reclassification as medium-risk
This article was originally published in Clinica
Executive Summary
The US FDA has reclassified full field digital mammography (FFDM) systems from high- to medium-risk devices. This should expedite the approval process, thus making it easier for firms to get these products to market.